Nevertheless, we believe that it is not the anti-LGI1 encephalitis that is not well controlled, but the static structural brain damage left after treatment, the atrophy in the left frontotemporal lobe, that result in structural drug-resistant epilepsy and intellectual disability. Here, LGI1 is linked to epilepsy.